Polarean Imaging plc (AIM:POLX)
0.0800
-0.0200 (-20.00%)
Inactive · Last trade price on Dec 22, 2025
Polarean Imaging Revenue
Polarean Imaging had revenue of $594.91K USD in the half year ending June 30, 2025, with 317.82% growth. This brings the company's revenue in the last twelve months to $2.56M, up 37.27% year-over-year. In the year 2024, Polarean Imaging had annual revenue of $3.09M with 246.82% growth.
Revenue (ttm)
$2.56M
Revenue Growth
+37.27%
P/S Ratio
0.52
Revenue / Employee
$98.65K
Employees
26
Market Cap
965.63K GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.09M | 2.20M | 246.82% |
| Dec 31, 2023 | 890.93K | -142.08K | -13.75% |
| Dec 31, 2022 | 1.03M | -152.42K | -12.86% |
| Dec 31, 2021 | 1.19M | 128.66K | 12.17% |
| Dec 31, 2020 | 1.06M | -1.24M | -54.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPolarean Imaging News
- 1 year ago - Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives - GlobeNewsWire
- 3 years ago - FDA Approves Polarean's XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the Evaluation of Lung Ventilation - GlobeNewsWire